SYNOPHYLATE Drug Patent Profile
✉ Email this page to a colleague
When do Synophylate patents expire, and when can generic versions of Synophylate launch?
Synophylate is a drug marketed by Cent Pharms and is included in one NDA.
The generic ingredient in SYNOPHYLATE is theophylline sodium glycinate. There is one drug master file entry for this compound. Additional details are available on the theophylline sodium glycinate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SYNOPHYLATE?
- What are the global sales for SYNOPHYLATE?
- What is Average Wholesale Price for SYNOPHYLATE?
Summary for SYNOPHYLATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Patent Applications: | 108 |
| DailyMed Link: | SYNOPHYLATE at DailyMed |
US Patents and Regulatory Information for SYNOPHYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cent Pharms | SYNOPHYLATE | theophylline sodium glycinate | ELIXIR;ORAL | 006333-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
